Acorda Therapeutics, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q1 2017 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Acorda Therapeutics, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q1 2017 to Q1 2024.
- Acorda Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending March 31, 2024 was $20.3M, a 8.85% decline year-over-year.
- Acorda Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending March 31, 2024 was $116M, a 2.22% decline year-over-year.
- Acorda Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $118M, a 0.79% decline from 2022.
- Acorda Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $119M, a 8.14% decline from 2021.
- Acorda Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $129M, a 15.6% decline from 2020.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)